CDKN2B-AS1 and neoplasm: Taken together, these findings show that CAF-derived MK acts on tumour cells by paracrine action, increasing lncRNA ANRIL expression in tumour cells and thus promoting the up-regulation of ABC family proteins MRP1 and ABCC2, which ultimately results in tumour cell resistance to cisplatin.